✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals

Kopran Ltd.

KOPRAN

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹835 Cr.
P/E
23.92

Kopran Ltd.

  • Kopran
  • NGL Fine-Chem
  • Shree Ganesh Remed.
  • TJI Pharma - Small Cap
FAQs on Kopran Ltd. Shareprice

Kopran has given lower returns compared to its competitors.
Kopran has grown at ~20.39% over the last 7yrs while peers have grown at a median rate of 21.59%

Kopran is expensive when considering the PE ratio, however latest EV/EBIDTA is < 3 yr avg EV/EBIDTA.
Latest PE of Kopran is 23.92, while 3 year average PE is 22.99.
Also latest EV/EBITDA of Kopran is 14.54 while 3yr average is 15.95.

View FAQ's On Business
Growth Table
  • Kopran Ltd.
  • NGL Fine-Chem
  • Shree Ganesh Remed.
Balance Sheet
  • Kopran Ltd.
  • NGL Fine-Chem
  • Shree Ganesh Remed.
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Kopran Ltd.
  • NGL Fine-Chem
  • Shree Ganesh Remed.
Cash Flow
  • Kopran Ltd.
  • NGL Fine-Chem
  • Shree Ganesh Remed.
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Kopran Ltd.
  • NGL Fine-Chem
  • Shree Ganesh Remed.
Quarterly Results
  • Kopran Ltd.
  • NGL Fine-Chem
  • Shree Ganesh Remed.
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF
FAQs on Kopran Ltd. Financials

Balance sheet of Kopran is strong.
It shouldn't have solvency or liquidity issues.

Yes, The net debt of Kopran is increasing.
Latest net debt of Kopran is ₹96.12 Crs as of Mar-25.
This is greater than Mar-24 when it was ₹70.91 Crs.

No, profit is decreasing.
The profit of Kopran is ₹34.91 Crs for TTM, ₹38.55 Crs for Mar 2025 and ₹50.96 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Kopran latest dividend payout ratio is 37.57% and 3yr average dividend payout ratio is 39.69%

Companies resources are allocated to majorly unproductive assets like Inventory

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech